• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2006-2016 年法国肠球菌中 oprtA 介导的利奈唑胺耐药的出现。

Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16.

机构信息

Université de Rennes 1, Inserm U1230, Rennes, France.

CHU de Caen, Service de Microbiologie, Caen, France.

出版信息

J Antimicrob Chemother. 2019 Jun 1;74(6):1469-1472. doi: 10.1093/jac/dkz097.

DOI:10.1093/jac/dkz097
PMID:30897199
Abstract

OBJECTIVES

To describe the epidemiological trend of linezolid-resistant enterococci (LRE) collected in France from 2006 to 2016 and to extensively characterize LRE isolates.

METHODS

The National Reference Center for Enterococci (NRC-Enc) received enterococcal isolates suspected to be VRE and/or LRE from all French hospitals between 2006 and 2016. LRE isolates were phenotypically characterized and their genomes were entirely sequenced by Miseq (Illumina). Transfer of linezolid resistance was attempted by filter mating experiments.

RESULTS

Out of 3974 clinical isolates of enterococci received at the NRC-Enc over the period, 9 (0.2%) were LRE (MICs 8 to >32 mg/L), including 6 Enterococcus faecium and 3 Enterococcus faecalis. This overall prevalence significantly increased over the study period, reaching 0.8% in 2016. The five LRE isolated before 2016 were vanA-positive E. faecium whereas strains isolated in 2016 (one E. faecium and three E. faecalis) were susceptible to vancomycin. None of these isolates was part of an outbreak, while E. faecium strains were assigned to four different STs [17 (1), 80 (3), 412 (1) and 650 (1)] and all three E. faecalis belonged to ST480. Except for the strain isolated in 2010, all LRE were positive for optrA, which was located on plasmids (5/8) or in the chromosome (3/8). Plasmid transfer of optrA was successful in three cases.

CONCLUSIONS

There has been a significant increase in the prevalence of LRE in France over time; this is due to the spread of optrA among E. faecium and E. faecalis human clinical isolates (VRE or not).

摘要

目的

描述 2006 年至 2016 年期间法国收集的利奈唑胺耐药肠球菌(LRE)的流行病学趋势,并对 LRE 分离株进行广泛表征。

方法

国家肠球菌参考中心(NRC-Enc)自 2006 年至 2016 年期间从法国所有医院接收疑似万古霉素耐药肠球菌(VRE)和/或利奈唑胺耐药肠球菌(LRE)的肠球菌分离株。LRE 分离株进行表型特征分析,并通过 Miseq(Illumina)对其基因组进行全序列测序。通过滤膜交配实验尝试转移利奈唑胺耐药性。

结果

在 NRC-Enc 收到的 3974 株肠球菌临床分离株中,有 9 株(0.2%)为 LRE(MICs 8 至 >32mg/L),包括 6 株屎肠球菌和 3 株粪肠球菌。在整个研究期间,这种总体流行率显著增加,到 2016 年达到 0.8%。2016 年之前分离的 5 株 LRE 为 vanA 阳性屎肠球菌,而 2016 年分离的菌株(1 株屎肠球菌和 3 株粪肠球菌)对万古霉素敏感。这些分离株均未发生疫情,屎肠球菌菌株被分为 4 种不同的 ST(17(1)、80(3)、412(1)和 650(1)),所有 3 株粪肠球菌均属于 ST480。除 2010 年分离的菌株外,所有 LRE 对 optrA 均呈阳性,该基因位于质粒(8/5)或染色体(8/3)上。在三种情况下,optrA 质粒转移成功。

结论

随着时间的推移,法国 LRE 的流行率显著增加;这是由于 optrA 在屎肠球菌和粪肠球菌人类临床分离株(VRE 或非 VRE)中的传播所致。

相似文献

1
Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16.2006-2016 年法国肠球菌中 oprtA 介导的利奈唑胺耐药的出现。
J Antimicrob Chemother. 2019 Jun 1;74(6):1469-1472. doi: 10.1093/jac/dkz097.
2
Genetic features of the poxtA linezolid resistance gene in human enterococci from France.法国人类肠球菌中 poxtA 利奈唑胺耐药基因的遗传特征。
J Antimicrob Chemother. 2021 Jul 15;76(8):1978-1985. doi: 10.1093/jac/dkab116.
3
Epidemiology and genetic diversity of linezolid-resistant Enterococcus clinical isolates in Belgium from 2013 to 2021.2013 年至 2021 年比利时利奈唑胺耐药肠球菌临床分离株的流行病学和遗传多样性。
J Glob Antimicrob Resist. 2024 Sep;38:21-26. doi: 10.1016/j.jgar.2024.04.010. Epub 2024 May 7.
4
Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance.波兰医院中耐利奈唑胺肠球菌:耐利奈唑胺的菌种、克隆性及决定因素
Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1279-1286. doi: 10.1007/s10096-017-2934-7. Epub 2017 Feb 14.
5
Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds.爱尔兰住院患者屎肠球菌和粪肠球菌的利奈唑胺耐药性:具有不同遗传背景的分离株中高流行的多药耐药基因 optrA 和 poxtA。
J Antimicrob Chemother. 2020 Jul 1;75(7):1704-1711. doi: 10.1093/jac/dkaa075.
6
Interregional spread in Spain of linezolid-resistant Enterococcus spp. isolates carrying the optrA and poxtA genes.西班牙耐林可霉素肠球菌属分离株中携带 optrA 和 poxtA 基因的区际传播。
Int J Antimicrob Agents. 2020 Jun;55(6):105977. doi: 10.1016/j.ijantimicag.2020.105977. Epub 2020 Apr 22.
7
LRE-Finder, a Web tool for detection of the 23S rRNA mutations and the optrA, cfr, cfr(B) and poxtA genes encoding linezolid resistance in enterococci from whole-genome sequences.LRE-Finder,一个用于检测肠球菌中 23S rRNA 突变和编码利奈唑胺耐药的 optrA、cfr、cfr(B) 和 poxtA 基因的 Web 工具,来自全基因组序列。
J Antimicrob Chemother. 2019 Jun 1;74(6):1473-1476. doi: 10.1093/jac/dkz092.
8
Genomic epidemiology reveals multiple mechanisms of linezolid resistance in clinical enterococci in China.基因组流行病学揭示了中国临床肠球菌中多种利奈唑胺耐药机制。
Ann Clin Microbiol Antimicrob. 2024 May 4;23(1):41. doi: 10.1186/s12941-024-00689-0.
9
The emerging problem of linezolid-resistant enterococci.耐(linezolid)利(novel)糖(tetracycline)肠球菌的新兴问题。
J Glob Antimicrob Resist. 2018 Jun;13:11-19. doi: 10.1016/j.jgar.2017.10.018. Epub 2017 Oct 31.
10
Distribution of the optrA gene in Enterococcus isolates at a tertiary care hospital in China.中国一家三级医院肠球菌分离株中 optrA 基因的分布。
J Glob Antimicrob Resist. 2019 Jun;17:180-186. doi: 10.1016/j.jgar.2019.01.001. Epub 2019 Jan 11.

引用本文的文献

1
Linezolid in the Focus of Antimicrobial Resistance of Species: A Global Overview of Genomic Studies.利奈唑胺在细菌耐药性研究中的焦点:基因组研究的全球概述
Int J Mol Sci. 2025 Aug 24;26(17):8207. doi: 10.3390/ijms26178207.
2
Genomic and clinical characterization of linezolid resistance in Enterococcus species from cancer patients in China.中国癌症患者肠球菌属中利奈唑胺耐药性的基因组和临床特征
BMC Infect Dis. 2025 Aug 7;25(1):989. doi: 10.1186/s12879-025-11371-x.
3
Duration of hospitalization increases the risk for long-term carriage of linezolid-resistant enterococci in critically ill patients.
住院时间延长会增加重症患者长期携带耐利奈唑胺肠球菌的风险。
Antimicrob Resist Infect Control. 2025 Apr 29;14(1):39. doi: 10.1186/s13756-025-01551-4.
4
Emergence of Linezolid Resistance Genes and (D) in an from Chicken.利奈唑胺耐药基因在鸡源中的出现及(D)(原文此处不完整,翻译可能存在偏差)
Antibiotics (Basel). 2025 Mar 24;14(4):337. doi: 10.3390/antibiotics14040337.
5
First Detection and Genomic Characterization of Linezolid-Resistant Clinical Isolates in Bulgaria.保加利亚耐利奈唑胺临床分离株的首次检测及基因组特征分析
Microorganisms. 2025 Jan 17;13(1):195. doi: 10.3390/microorganisms13010195.
6
Persistence of Daptomycin-Resistant and Vancomycin-Resistant Enterococci in Hospitalized Patients with Underlying Malignancies: A 7-Year Follow-Up Study.患有潜在恶性肿瘤的住院患者中耐达托霉素和耐万古霉素肠球菌的持续存在:一项7年随访研究
Microorganisms. 2024 Aug 14;12(8):1676. doi: 10.3390/microorganisms12081676.
7
Genomic epidemiology reveals multiple mechanisms of linezolid resistance in clinical enterococci in China.基因组流行病学揭示了中国临床肠球菌中多种利奈唑胺耐药机制。
Ann Clin Microbiol Antimicrob. 2024 May 4;23(1):41. doi: 10.1186/s12941-024-00689-0.
8
Genomic characterization of vancomycin-resistant clonal complex 17 isolated from urine in tertiary hospitals in Northeastern Thailand.泰国东北部三级医院尿液中分离出的耐万古霉素克隆复合体17的基因组特征分析
Front Microbiol. 2024 Jan 19;14:1278835. doi: 10.3389/fmicb.2023.1278835. eCollection 2023.
9
Circular intermediate-mediated horizontal transfer of the chromosome-encoded gene in multi-drug resistant from swine sources.猪源多药耐药菌中染色体编码基因的环状中间体介导的水平转移
Front Microbiol. 2023 Dec 22;14:1274245. doi: 10.3389/fmicb.2023.1274245. eCollection 2023.
10
Detection of Genes Related to Linezolid Resistance (, , and ) in Clinical Isolates of . from Humans: A First Report from Iran.在来自人类的耐甲氧西林金黄色葡萄球菌临床分离株中检测与利奈唑胺耐药相关的基因(、和):来自伊朗的首次报告。
Adv Biomed Res. 2023 Jul 31;12:205. doi: 10.4103/abr.abr_74_23. eCollection 2023.